Back to Main

Faculty Detail    
Name DANA VICTOR RIZK
 
Campus Address ZRB 614 Zip 0007
Phone  (205) 934-9509
E-mail  drizk@uab.edu
Other websites Physician Profile
     


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Med - Nephrology  Med - Nephrology Professor
Center  Ctr for Clinical & Translational Sci  Ctr for Clinical & Translational Sci Professor
Center  Nephrology Research & Training Center  Nephrology Research & Training Center Professor

Biographical Sketch 
POST DOCTORAL TRAINING: 2003-2004 Nephrology Fellow Emory University Hospital 2002-2003 Medicine Chief resident Emory University Hospital 2001-2002 Nephrology fellow Emory University Hospital 2000-2001 Internal Medicine Resident (PGY-3) Emory University Hospital 1998-2000 Internal Medicine Resident (PGY-1/2) St Louis University Hospital 1997-1998 Internal Medicine Resident (PGY-1) American University of Beirut ACADEMIC/HOSPITAL APPOINTMENTS: 2010-present: Director of the Chronic Kidney Disease clinic at the Kirklin clinic. 2008-present: Director of Davita East Dialysis Unit 2012-present: Associate Professor of Medicine University of Alabama at Birmingham 2008-2012: Assistant Professor of Medicine University of Alabama at Birmingham 2006-2008: Assistant Professor of Medicine Emory University 2004-2005: Instructor of Medicine Emory University HONORS/AWARDS: 2010: Outstanding Division Teacher in Nephrology from the UAB department of Medicine 2005-2006: Emory University Golden Apple Award for excellence in teaching 2004: Outstanding Presentation Award at the National Kidney Foundation Meeting, Georgia Chapter Sea Island GA 2003: Recipient of Certificate of Appreciation for Outstanding Contribution to the Education of PA students. Department of Family and Preventive Medicine, Emory University

Society Memberships
Organization Name Position Held Org Link
American Society of Nephrology  Member   
Medical Review Borad for ESRD Network 8  Co-Chair   
National Kidney Foundation  Member   
Southern Society of Clinical Investigation  Member elect   
Task Force for NKF Nephrology and Transplant Update (GA and AL chapter)  Member   



Research/Clinical Interest
Title
1-Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
Description
Dr Dana Rizk is Tenured Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB). She also serves as Director of Clinical Trials Research in the Division of Nephrology and as Medical Director for the Clinical Trials Administrative Office (part of the CCTS) at UAB. She has a passion for education and has served as a member of the Clinical Competency Committees for the Internal Medicine as well as the Nephrology Programs. She is the recipient of several teaching awards. Her clinical and research interests revolve around glomerular diseases and, in particular IgA Nephropathy (IgAN). She has served as the site principal investigator on many clinical trials and is part of several multi-disciplinary translational research projects focused on the role of biomarkers in the diagnosis and prognosis of IgAN. Her research efforts have resulted in more than 55 peer-reviewed publications in prestigious medical journals including the New England Journal of Medicine.

Selected Publications 
Publication PUBMEDID
Rajasekaran A, Rizk DV. The Forgotten Cost of Nephrotic Syndrome to Patients and Caregivers in the United States. Kidney360. 2022 Apr 15;3(6):991-992.  35987175 
Targeting the Alternative Complement Pathway with Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study  37180505 
Gutiérrez OM, Judd SE, Muntner P, Rizk DV, McClellan WM, Safford MM, Cushman M, Kissela BM, Howard VJ, Warnock DG.
Racial differences in albuminuria, kidney function, and risk of stroke.Neurology. 2012 Oct 16;79(16):1686-92. 
22993285 
Zuber K, Davis J, Rizk D. Kidney Disease Education One Year After the Medicare Improvement of Patients and Providers Act: A Survey of the US Nephrology Practices. Am J Kidney Dis. 2012 Jun;59(6):892-4  22464878 
Rizk DV, Gutierrez O, Levitan EB, McClellan WM, Safford M, Soliman EZ, Warnock DG, Muntner P. Prevalence and Prognosis of Unrecognized Myocardial Infarctions in Chronic Kidney Disease. Nephrol Dial Transplant. 2012 Sep;27(9):3482-8.
 
22167594 
Muntner P, Bowling CB, Gao L, Rizk D, Judd S, Tanner RM, McClellan W, Warnock DG. Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. Clin J Am Soc Nephrol. 2011 Sep; 6(9):2200-7  21737849 
Rizk DV, Warnock DG. Warfarin-related nephropathy: another newly recognized complication of an old drug. Kidney Int. 2011 Jul; 80(2):131-3  21720303 
Dana Rizk, Claudine Jurkovitz, Emir Veledar,Susan Bagby,Deborah A.Baumgarten, Frederic Rahbari-Oskoui, Theodore Steinman, and Arlene B. Chapman. Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients not yet on Dialysis. Clin J Am Soc Nephrol 4:560-566,2009  19261830 
Badero OJ, Schlanger L, RizkD. Gadolinium nephrotoxicity: case report of a rare entity and review of the literature Clin Nephrol.2008Dec;70(6):518-22  19049710 
D Rizk MD; AB Chapman MD. Treatment of ADPKD: The New Horizon for children with ADPKD. Pediatr Nephrol. 2008 Jul;23(7):1029-36. Epub 2008 Feb 8. Review  18259779 
Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Rizk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic resonance measurements of renal blood flow and disease progreesion in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20  17699395 
Arlene Chapman MD, Frederic Rahbari-Oskoui MD, Stine Errboe BMSc and Dana Rizk MD. Hypertension in Autosomal Dominant Polycystic Kidney Disease. US Nephrology, 2010;5(1):54-9   
D Rizk MD; AB Chapman MD. Inherited Cystic Kidney Diseases. Chapter for the “Primer in Kidney Diseases”, 2006.  37180505 

Keywords
Glomerular diseases, IgA nephropathy, Membranous nephropathy, Minimal change disease, Focal segmental glomerulosclerosis